Quote | Super Quote
22535 HUBEONE@EC2605A (CALL)
RT Nominal unchange0.010 0.000 (0.000%)

08/05/2026 14:34

BOCI raises BeOne Medicines (06160) to HKD240

  [ET Net News Agency, 8 May 2026] BOCI raised the target price for BeOne Medicines (06160) to HKD240 from HKD196 and maintained the "buy" rating.
  The research house said it raises 2026-27 revenue forecasts by 3-7%, primarily driven by stronger Brukinsa assumptions and improving operating leverage. (rc)

Back to Related News

Remark: Real time quote last updated: 11/05/2026 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.